Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.asjsur.2023.08.076 | DOI Listing |
Cancer Cell Int
June 2024
Department of Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Cancer Hospital of Dalian University of Technology, No.44 Xiaoheyan Road, Dadong District, Shenyang, Liaoning Province, 110042, P. R. China.
Background: Globally, breast cancer in women is the fifth leading cause of cancer death. There is an urgent need to explore the molecular mechanism of breast cancer proliferation and metastasis.
Method: TCGA database analysis was used to analyze genes expression in breast cancer and normal samples and the association between gene expression and prognosis.
Asian J Surg
December 2023
Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, PR China. Electronic address:
Mol Biotechnol
August 2024
Central Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua City, 321000, Zhejiang Province, China.
Glycolysis is a shared feature in various cancers including lung adenocarcinoma (LUAD). Testis Expressed 19 (TEX19) is correlated with cancer progression. But its effect on LUAD remains an unanswered question.
View Article and Find Full Text PDFBiofabrication
May 2023
Biomedical Engineering, The University of Texas at El Paso, El Paso, TX, United States of America.
Mol Genet Genomic Med
July 2021
Doping Research Chair, Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Background: Testis expressed 19 (TEX19) is a specific human stem cell gene identified as cancer-testis antigen (CTA), which emerged as a potential therapeutic drug target. TEX19.1, a mouse paralog of human TEX19, can interact with LINE-1 retrotransposable element ORF1 protein (LIRE1) and subsequently restrict mobilization of LINE-1 elements in the genome.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!